# In Vivo CAR-T for Refractory Graves' Disease

> **NCT07333677** · EARLY_PHASE1 · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 5 (estimated)

## Conditions studied

- Graves' Disease

## Interventions

- **BIOLOGICAL:** In Vivo CAR-T Therapy

## Key facts

- **NCT ID:** NCT07333677
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333677, "In Vivo CAR-T for Refractory Graves' Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07333677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*